D. Haydar Laboratory
About the Lab
The D. Haydar Laboratory works on designing effective, long-lasting, and safe cellular immunotherapies for childhood brain cancer. CAR T cell therapy is an innovative technology based on adoptive transfer of antigen-specific T cells engineered to elicit a clinically effective and specific immune response against tumor cells. Our aim is to investigate mechanisms responsible for the lack of CAR T cell efficacy in pediatric brain tumors using cutting-edge technologies and innovative animal models that recapitulate human disease and barriers for adoptive immunotherapies.
-
Lab Focus Areas
Cell Enhancement and Technologies for Immunotherapy
Tumor Immunology
-
Partnerships
Institute for Biomedical Sciences (IBS) Program, George Washington University School of Medicine and Health Sciences
Howard University Graduate School -
Contact
Dalia Haydar, Pharm.D., Ph.D. D. Haydar Laboratory dhaydar@childrensnational.org 202-476-1035
Related News
-
Driving pediatric breakthroughs through 2023
February 15, 2024 -
NexTGen team assembles to delve into progress on CAR T-cell therapies
November 21, 2023 -
Cell & Gene Therapy in the DMV: Experts collaborate for cures
November 15, 2023